12:00 AM
Nov 03, 2003
 |  BC Week In Review  |  Company News  |  Deals

Chiron, Pfizer deal

CHIR non-exclusively licensed to PFE rights to research, develop and commercialize therapeutics against certain hepatitis C virus (HCV)...

Read the full 66 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >